Abstract：
OBJECTIVE: The aim of the current study was to investigate whether the artery-first approach (AFA) improved surgical outcomes of pancreaticoduodenectomy (PD) at our non-high-volume center.
METHODS: We retrospectively reviewed data on 121 consecutive patients who underwent PD between January 2009 and December 2018. The perioperative data of 49 patients who underwent conventional PD (conventional group) and 72 patients who underwent PD via artery-first approach were analyzed and compared to assess the effectiveness of the AFA.
RESULTS: Although no significant difference was observed between the two groups overall, in those with pancreatic cancer, the duration of surgery, intraoperative blood loss and transfusion rate in the AFA group (n=33) were significantly lower than those for the conventional group (n=11) (p=0.011, p=0.021 and p=0.038 respectively).
CONCLUSIONS: AFA can be used to reduce the operative time, intraoperative blood loss, and transfusion rate in patients with pancreatic cancer.
METHODS: We retrospectively reviewed data on 121 consecutive patients who underwent PD between January 2009 and December 2018. The perioperative data of 49 patients who underwent conventional PD (conventional group) and 72 patients who underwent PD via artery-first approach were analyzed and compared to assess the effectiveness of the AFA.
RESULTS: Although no significant difference was observed between the two groups overall, in those with pancreatic cancer, the duration of surgery, intraoperative blood loss and transfusion rate in the AFA group (n=33) were significantly lower than those for the conventional group (n=11) (p=0.011, p=0.021 and p=0.038 respectively).
CONCLUSIONS: AFA can be used to reduce the operative time, intraoperative blood loss, and transfusion rate in patients with pancreatic cancer.
摘要：
目的：本研究的目的是探讨动脉优先入路（AFA）是否能改善非高容量中心胰十二指肠切除术（PD）的手术结果。
方法：我们回顾性回顾了2009年1月至2018年12月期间接受PD的121例连续患者的数据。对49例接受常规PD（常规组）的患者和72例经动脉先行入路接受PD的患者的围手术期数据进行分析和比较，以评估AFA的有效性。
结果：虽然两组总体上没有显著差异，在胰腺癌患者中，手术的持续时间,AFA组（n=33）的术中出血量和输血率明显低于常规组（n=11）（分别为p=0.011，p=0.021和p=0.038）。
结论：AFA可以减少手术时间，术中失血,胰腺癌患者的输血率。
方法：我们回顾性回顾了2009年1月至2018年12月期间接受PD的121例连续患者的数据。对49例接受常规PD（常规组）的患者和72例经动脉先行入路接受PD的患者的围手术期数据进行分析和比较，以评估AFA的有效性。
结果：虽然两组总体上没有显著差异，在胰腺癌患者中，手术的持续时间,AFA组（n=33）的术中出血量和输血率明显低于常规组（n=11）（分别为p=0.011，p=0.021和p=0.038）。
结论：AFA可以减少手术时间，术中失血,胰腺癌患者的输血率。
